thors [1] . Having a visionary idea, Dr. Marluce Bibbo, Editor-in-Chief of the journal at that time, invited 17 cytopathologists and cytotechnologists, from 12 countries and representing 4 continents, to discuss how new technology is being applied and what advances and challenges we are predicting for the future. Ten years on, and to celebrate 60 Years of Acta Cytologica , Dr. Kari Syrjänen, the current Editor-in-Chief, presented us with the challenge of describing the impact of this article in the development of our specialty as well as in the increase of knowledge at a conceptual level [2] .There were several ways to present this discussion, but we decided to do it according to the different questions originally formulated in the article, and to then verify if the expectations and projections made at that time are still of interest, have changed, or are no longer in place. We also comment on some of the new developments in the technology and the biomarkers that were not predicted at that time but are now implemented in most pathology laboratories.1. The Role of Morphology. For several decades, cytopathologists have practiced diagnostic cytopathology of nongynecologic specimens based on morphologic features. Do you think morphologic features will still play an important role 10 years from now? The moderator and editor was Marluce Bibbo, previous Editor-in-Chief of Acta Cytologica , and 17 participants from countries throughout the world were asked to answer how new technologies were being applied in their respective laboratories and whether future advances and challenges can be predicted. Ten years later, two previous participants in this Golden Anniversary Cytology Symposium were asked by Kari Syrjänen, current Editor-in-Chief of Acta Cytologica , to make a reappraisal of the 2007 predictions.